Her tumor was positive for mutational Sig3, and BROCA analysis revealed a hypermethylation of BRCA1 and a loss-of-function mutation in TP53. Her tumor was enriched for CD163 + IBA1 + CD11b + macrophages and exhausted CD8 + T-cells (Fig. 4b). This evidence concerns the gene CD8A and neoplasm.